Resveratrol supplementation significantly influences obesity measures: a systematic review and dose–response meta‐analysis of randomized controlled trials

@article{Mousavi2019ResveratrolSS,
  title={Resveratrol supplementation significantly influences obesity measures: a systematic review and dose–response meta‐analysis of randomized controlled trials},
  author={S. M. Mousavi and Alireza Milajerdi and Ali Sheikhi and Hamed Kord-Varkaneh and Christine Feinle-Bisset and Bagher Larijani and Ahmad Esmaillzadeh},
  journal={Obesity Reviews},
  year={2019},
  volume={20},
  pages={487 - 498}
}
This study aimed to summarize earlier randomized controlled trials on the effects of resveratrol supplementation on body weight (BW), body mass index (BMI), waist circumference (WC) and fat mass (FM). We searched PubMed, SCOPUS, Cochrane Library and Google Scholar from inception to April 2018 using relevant keywords. All clinical trials investigating the effects of resveratrol supplementation on BW, BMI, WC and FM in adults were included. Overall, 28 trials were included. Pooled effect sizes… Expand
The Effect of Resveratrol Supplementation on Cardio‐Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double‐Blind Controlled Trial
TLDR
It was found that 8‐week resveratrol supplementation produced useful effects on some cardio‐metabolic parameters in patients with T2DM, and more studies are needed to confirm these findings. Expand
The Effects of Polyphenol Supplementation in Addition to Calorie Restricted Diets and/or Physical Activity on Body Composition Parameters: A Systematic Review of Randomized Trials
TLDR
The results do not yet support polyphenol supplementation as a complementary strategy for enhancing the effectiveness of CRD and PA on weight and fat loss, but this review suggests that isoflavone and soy products combined with lifestyle changes, especially exercise, provide additional anti-obesity effects in postmenopausal women. Expand
The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials.
TLDR
Current evidence does not support supplementation with resveratrol for the management of cardiometabolic risk factors in patients with T2D, MetS, and NAFLD. Expand
What are the effects of N-acetylcysteine supplementation on anthropometric indices? A systematic review and meta-analysis of clinical trials
TLDR
A systematic review and meta-analysis of randomized clinical trials to examine whether NAC consumption can result in any changes in anthropometric indices indicated no significant effect of NAC supplementation on obesity indices. Expand
The effect of Alpha‐lipoic acid supplementation on endothelial function: A systematic review and meta‐analysis
TLDR
The results showed that ALA supplementation appears to improve the EF, however, the role of ALA supplements in improving other biomarkers of EF requires further research. Expand
Usefulness of resveratrol supplementation in decreasing cardiometabolic risk factors comparing subjects with metabolic syndrome and healthy subjects with or without obesity: meta-analysis using multinational, randomised, controlled trials
TLDR
Despite some heterogeneity in the populations, RES supplementation seems to improve cardiometabolic health, decreasing some risk factors associated with CVD. Expand
Resveratrol and metabolic health in COPD: A proof-of-concept randomized controlled trial.
TLDR
The results do not confirm previously reported positive effects of resveratrol on skeletal muscle mitochondrial function in patients with COPD, but show an unexpected decline in lean mass. Expand
Multidimensional perspective of obesity; prevention to treatment
An increasing prevalence of overweight and obesity across the world can lead to serious health complications. The present narrative review highlighted the results of research on obesity managementExpand
Effects of saffron (Crocus sativus L.) supplementation on inflammatory biomarkers: A systematic review and meta‐analysis
TLDR
The overall results indicated that saffron supplementation did not affect inflammatory cytokines and further high‐quality studies are needed to firmly establish the clinical efficacy of supplemental saffrons on inflammatory biomarkers. Expand
Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS.
TLDR
Resveratrol improved menstrual cyclicity and hair loss, even though levels of androgens, insulin and lipids remained unchanged, and did not interfere with the thyroid, liver and kidney functions. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 75 REFERENCES
Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials
TLDR
The favourable effect of resveratrol emerging from the current meta-analysis suggests the possible use of this nutraceutical as active compound in order to promote cardiovascular health, mostly when used in high daily dose (≥300 mg/day) and in diabetic patients. Expand
Effect of Nigella sativa supplementation on obesity indices: A systematic review and meta-analysis of randomized controlled trials.
TLDR
A significant effect of Nigella sativa supplementation on BW and BMI in adults is found, however, the effect of NS supplementation on WC was not significant in this meta-analysis. Expand
Resveratrol supplementation and plasma adipokines concentrations? A systematic review and meta‐analysis of randomized controlled trials
TLDR
Resveratrol significantly improves adiponectin but does not affect leptin concentrations, and additional studies are required to further evaluate the potential benefits of resver atrol on adipokines in humans. Expand
The Effects of Resveratrol Supplementation in Overweight and Obese Humans: A Systematic Review of Randomized Trials.
TLDR
There is currently insufficient evidence to support the recommendation of resveratrol supplements in management of obesity, however, there were significant but not entirely consistent anti-inflammatory effects after resver atrol supplementation in overweight and obese individuals. Expand
Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.
TLDR
The present meta-analysis indicates that resveratrol consumption significantly decreases the SBP level at the higher dose, while resver atrol has no significant effects on DBP levels. Expand
No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial
TLDR
RSV treatment did not improve inflammatory status, glucose homeostasis, blood pressure, or hepatic lipid content in middle-aged men with MetS, and RSVhigh significantly increased total cholesterol, LDL cholesterol, and fructosamine levels compared with placebo. Expand
Polyphenols and Their Role in Obesity Management: A Systematic Review of Randomized Clinical Trials
TLDR
Results suggest that further research is required before supporting a potential role of polyphenols in reducing weight in overweight and obese individuals, and several studies indicated that polyphenol might be effective in preventing small increases in weight during periods of overfeeding rather than reducing weight as such. Expand
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.
TLDR
Resveratrol significantly improves glucose control and insulin sensitivity in persons with diabetes but does not affect glycemic measures in nondiabetic persons. Expand
Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
TLDR
CR diet with moderate weight loss has favorable effects on NAFLD, and resveratrol supplementation induced weight loss but failed to mimic other aspects of CR diet. Expand
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
TLDR
It is shown that 12-week supplementation of 500 mg resveratrol does not have any beneficial effect on anthropometric measurements, insulin resistance markers, lipid profile and blood pressure; however, it reduced ALT and hepatic steatosis in patients with NAFLD. Expand
...
1
2
3
4
5
...